Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints Jeff Capello as executive VP and CFO

He will lead the company's business and finance planning functions

Jeff CapelloBiotechnology company Biogen has appointed Jeff Capello as its executive vice president and chief financial officer, roles which will see him lead the company’s business planning, tax, treasury, internal audit, accounting and investor relations functions.

Reporting to chief executive officer of Biogen, Michel Vounatsos, Capello will also become a member of the executive committee and he will be based in its Massachusetts office in the US.

He said: “I am very excited to join Biogen, a company which is recognised as a pioneer and a leader in treating neurological diseases and I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients.”

Capello brings 26 years of experience in finance to Biogen, with his most recent role being executive vice president and chief financial officer at Beacon Health Options.

His career experience has seen him serve in various positions for Monomy Advisors, Ortho Clinical Diagnostics, Boston Scientific Corporation and Perkin Elmer.

Vounatsos said: “We are fortunate to have Jeff join Biogen given the depth and breadth of his experience.

“He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline.”

5th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics